Serum Institute of India seeks emergency use nod for Covishield
Serum Institute of India (SII) has applied for emergency use authorization of the first Made in India Covid-19 vaccine, Covishield."As promised, before the end of 2020, @SerumInstIndia has applied for emergency use authorisation for the…